182 related articles for article (PubMed ID: 3931905)
1. Enzymes of uracil catabolism in normal and neoplastic human tissues.
Naguib FN; el Kouni MH; Cha S
Cancer Res; 1985 Nov; 45(11 Pt 1):5405-12. PubMed ID: 3931905
[TBL] [Abstract][Full Text] [Related]
2. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
Ho DH; Townsend L; Luna MA; Bodey GP
Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956
[TBL] [Abstract][Full Text] [Related]
3. Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay.
Traut TW; Loechel S
Biochemistry; 1984 May; 23(11):2533-9. PubMed ID: 6433973
[TBL] [Abstract][Full Text] [Related]
4. A radiochemical assay for beta-ureidopropionase using radiolabeled N-carbamyl-beta-alanine obtained via hydrolysis of [2-(14)C]5, 6-dihydrouracil.
Van Kuilenburg AB; Van Lenthe H; Van Gennip AH
Anal Biochem; 1999 Aug; 272(2):250-3. PubMed ID: 10415095
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
Naguib FN; Hao SN; el Kouni MH
Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 6-azauracil on beta-alanine metabolism in rat.
Tamaki N; Fujimoto S; Mizota C; Kaneko M; Kikugawa M
J Nutr Sci Vitaminol (Tokyo); 1989 Oct; 35(5):451-61. PubMed ID: 2632679
[TBL] [Abstract][Full Text] [Related]
8. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells.
Shiotani T; Hashimoto Y; Tanaka T; Irino S
Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts.
Tatsumi K; Fukushima M; Shirasaka T; Fujii S
Jpn J Cancer Res; 1987 Jul; 78(7):748-55. PubMed ID: 3114201
[TBL] [Abstract][Full Text] [Related]
10. Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes.
Rosenbaum K; Jahnke K; Curti B; Hagen WR; Schnackerz KD; Vanoni MA
Biochemistry; 1998 Dec; 37(50):17598-609. PubMed ID: 9860876
[TBL] [Abstract][Full Text] [Related]
11. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.
Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
Pharmacogenet Genomics; 2008 Jan; 18(1):25-35. PubMed ID: 18216719
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidine-degrading enzymes. Purification and properties of beta-ureidopropionase of Euglena gracilis.
Wasternack C; Lippmann G; Reinbotte H
Biochim Biophys Acta; 1979 Oct; 570(2):341-51. PubMed ID: 115499
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation.
Harada M; Nishitani H; Koga K; Miura I; Kimura A
Jpn J Cancer Res; 1993 Feb; 84(2):197-202. PubMed ID: 8463136
[TBL] [Abstract][Full Text] [Related]
15. Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.
Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
Pharmacogenet Genomics; 2007 Nov; 17(11):973-87. PubMed ID: 18075467
[TBL] [Abstract][Full Text] [Related]
16. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
17. Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level.
Van Kuilenburg AB; Van Lenthe H; Assmann B; Göhlich-Ratmann G; Hoffmann GF; Bräutigam C; Wevers RA; Van Gennip AH
J Inherit Metab Dis; 2001 Dec; 24(7):725-32. PubMed ID: 11804209
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer.
Heslin MJ; Yan J; Weiss H; Shao L; Owens J; Lucas VS; Diasio RB
Cancer Chemother Pharmacol; 2003 Nov; 52(5):399-404. PubMed ID: 12904894
[TBL] [Abstract][Full Text] [Related]
19. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase.
Tatsumi K; Yamauchi T; Kiyono K; Kishi K; Yanagihara Y; Imaoka T; Kawaguchi T; Kubo M
J Biochem; 1993 Dec; 114(6):912-8. PubMed ID: 8138551
[TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine.
Ohse M; Matsuo M; Ishida A; Kuhara T
J Mass Spectrom; 2002 Sep; 37(9):954-62. PubMed ID: 12271438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
